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CORRECTION
Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The Relation Between Patients’ Outcomes and the Volume of
Cardioverter-Defibrillator Implantation Procedures Performed by Physicians Treating Medicare Beneficiaries. J Am Coll Cardiol
2005;46:1536 – 40.
The volume cutpoints in the first row and the last two rows of Table 1 were printed incorrectly. The full correct table is printed below.
The authors apologize for this error.
doi:10.1016/j.jacc.2005.10.019
Table 1. Baseline Characteristics of Patients According to Physician-Volume Quartile
ICD Annualized Volume
1–10 11–18 19–28 29
p Value(n  2,487) (n  2,559) (n  2,336) (n  2,472)
Age (yrs)
65–69 562 (22.6%) 593 (23.2%) 507 (21.7%) 564 (22.8%) 0.38
70–74 712 (28.6%) 748 (29.2%) 690 (29.5%) 727 (29.4%)
75–79 734 (29.5%) 729 (28.5%) 707 (30.3%) 676 (27.4%)
80–84 373 (15.0%) 384 (15.0%) 320 (13.7%) 403 (16.3%)
85 106 (4.3%) 105 (4.1%) 112 (4.8%) 102 (4.1%)
Female 536 (21.6%) 569 (22.2%) 489 (20.9%) 536 (21.7%) 0.74
Race
White 2,251 (90.5%) 2,386 (93.2%) 2,155 (92.3%) 2,313 (93.6%) 0.01
Black 163 (6.6%) 117 (4.6%) 137 (5.9%) 121 (4.9%)
Other 73 (2.9%) 56 (2.2%) 44 (1.9%) 38 (1.5%)
Charlson comorbidity score
0 1,197 (48.1%) 1,144 (44.7%) 1,104 (47.3%) 1,095 (44.3%) 0.18
1 800 (32.2%) 892 (34.9%) 785 (33.6%) 858 (34.7%)
2 350 (14.1%) 388 (15.2%) 322 (13.8%) 376 (15.2%)
3 or more 140 (5.6%) 135 (5.3%) 125 (5.4%) 143 (5.8%)
Urgency of admission
Outpatient 244 (9.8%) 233 (9.1%) 255 (10.9%) 196 (7.9%) 0.01
Elective 726 (29.2%) 711 (27.8%) 708 (30.3%) 775 (31.4%)
Urgent 710 (28.6%) 707 (27.6%) 710 (30.4%) 829 (33.5%)
Emergency 807 (32.5%) 908 (35.5%) 663 (28.4%) 672 (27.2%)
Pacemaker annualized volume 0.01
1–20 1,309 (52.6%) 586 (22.9%) 349 (14.9%) 182 (7.4%)
64 145 (5.8%) 380 (14.9%) 754 (32.3%) 1,184 (47.9%)
ICD  implantable cardioverter-defibrillator.
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